Equillium (NASDAQ:EQ) Price Target Lowered to $5.50 at HC Wainwright

Equillium (NASDAQ:EQ – Get Rating) had its target price cut by HC Wainwright from $20.00 to $5.50 in a research report report published on Monday morning, The Fly reports. HC Wainwright also issued estimates for Equillium’s Q1 2023 earnings at $0.05 EPS, Q2 2023 earnings at ($0.24) EPS, Q3 2023 earnings at ($0.26) EPS, Q4 […]

Related Keywords

Stifel Nicolaus ,Daniel Mark Bradbury ,Equillium Company Profile ,Equillium Inc ,Victory Capital Management Inc ,True North Advisors ,Wealth Concepts ,Callan Capital ,Get Rating ,Stock Down ,Capital Management ,North Advisors ,Street Corp ,Integrated Wealth Concepts ,Equillium Daily ,Equillium ,Nasdaq Eq ,Eq ,Medical ,Lower Price Target ,Hc Wainwright ,